Boone Capital Management
Latest statistics and disclosures from Boone Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MIRM, IONS, CI, MDT, TFX, and represent 55.46% of Boone Capital Management's stock portfolio.
- Added to shares of these 10 stocks: TFX (+$33M), GRDN (+$24M), AZN (+$22M), AVNS (+$17M), CI (+$11M), BMRN (+$7.7M), IONS (+$6.2M), UNH, BBIO, TENX.
- Started 5 new stock positions in TENX, GRDN, TFX, AVNS, AZN.
- Reduced shares in these 9 stocks: , AstraZeneca (-$20M), HQY (-$20M), LIVN (-$18M), RAPT (-$16M), TYRA (-$11M), KOD (-$8.5M), WVE (-$6.0M), MDT.
- Sold out of its positions in AstraZeneca, HQY, NBIX, RAPT, TYRA, LIVN, WVE.
- Boone Capital Management was a net buyer of stock by $8.9M.
- Boone Capital Management has $326M in assets under management (AUM), dropping by 2.45%.
- Central Index Key (CIK): 0001882053
Tip: Access up to 7 years of quarterly data
Positions held by Boone Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Boone Capital Management
Boone Capital Management holds 13 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals (MIRM) | 11.9 | $39M | 421k | 92.38 |
|
|
| Ionis Pharmaceuticals (IONS) | 11.5 | $38M | +19% | 501k | 75.09 |
|
| Cigna Corp (CI) | 11.2 | $37M | +42% | 138k | 266.75 |
|
| Medtronic SHS (MDT) | 10.6 | $35M | -7% | 398k | 86.65 |
|
| Teleflex Incorporated (TFX) | 10.2 | $33M | NEW | 279k | 119.61 |
|
| BioMarin Pharmaceutical (BMRN) | 9.5 | $31M | +33% | 548k | 56.49 |
|
| Guardian Pharmacy Svcs Cl A (GRDN) | 7.3 | $24M | NEW | 631k | 37.66 |
|
| Astrazeneca Ord (AZN) | 6.7 | $22M | NEW | 110k | 197.22 |
|
| UnitedHealth (UNH) | 6.6 | $21M | +28% | 79k | 270.59 |
|
| Bridgebio Pharma (BBIO) | 5.2 | $17M | +23% | 229k | 74.26 |
|
| Halyard Health (AVNS) | 5.1 | $17M | NEW | 1.2M | 14.01 |
|
| Kodiak Sciences (KOD) | 3.3 | $11M | -44% | 281k | 38.12 |
|
| Tenax Therapeutics Com New (TENX) | 1.0 | $3.2M | NEW | 200k | 15.99 |
|
Past Filings by Boone Capital Management
SEC 13F filings are viewable for Boone Capital Management going back to 2022
- Boone Capital Management 2026 Q1 filed May 15, 2026
- Boone Capital Management 2025 Q4 filed Feb. 17, 2026
- Boone Capital Management 2025 Q3 filed Nov. 14, 2025
- Boone Capital Management 2025 Q2 filed Aug. 14, 2025
- Boone Capital Management 2025 Q1 filed May 15, 2025
- Boone Capital Management 2024 Q4 filed Feb. 14, 2025
- Boone Capital Management 2024 Q3 filed Nov. 14, 2024
- Boone Capital Management 2024 Q2 filed Aug. 14, 2024
- Boone Capital Management 2024 Q1 filed May 15, 2024
- Boone Capital Management 2023 Q4 filed Feb. 14, 2024
- Boone Capital Management 2023 Q3 filed Nov. 14, 2023
- Boone Capital Management 2023 Q2 filed Aug. 14, 2023
- Boone Capital Management 2023 Q1 filed May 15, 2023
- Boone Capital Management 2022 Q4 filed Feb. 14, 2023